Researchers at the University of Bayreuth are working to understand the regulatory functions of noncoding RNAs. This expands the foundations of neuroscience and provides valuable insight into the plasticity of the nervous system.
In the small town of Ruhstorf an der Rott, researchers at the Technology Center for Energy are tackling the big sustainability questions of our time: How should we design energy systems of the future?
Why do blood clots develop in the first place—and why do they tend to recur? LMU researcher Konstantin Stark believes that the answers lie in the immune system.
Prof. Jürgen Groll is one of the driving forces behind the Würzburg Center of Polymers for Life. In this interview, he discusses the new center—and the challenges involved in 3D printing living tissue.
SciFiMed is a multi-disciplinary project that combines fundamental immunological research with novel nanomaterial biosensor development translated into proof-of-principle diagnostics. International experts as well as biotechnology enterprises and health institutions are involved in the project.
With more than 330 million cars on European roads, millions of tons of end-of-life tires are produced each year. Researchers at FHWS are developing methods of recycling elastomers that could give these tires new life.
From junior research group leader to full professor and spokesperson of the Research Center for Infectious Diseases (ZINF) at the University of Würzburg. This is the scientific career path of Cynthia Sharma.
At the University of Bayreuth, academia and industry have partnered to form the TADFlife innovative training network. Together, they are working to develop sustainable technologies by improving the lifetime and energy efficiency of blue OLEDs.
David Baker, professor at the University of Washington in Seattle, is to be awarded the Nobel Prize in Chemistry. The biochemist has been a Distinguished Affiliated Professor at the Technical University of Munich (TUM) since 2017. He receives the prize for his work in the field of computational protein design.
Researchers from Würzburg and Berlin present a new molecule for visualising the sphingomyelin metabolism. This offers prospects for innovative therapeutic approaches in infection research.
